Centene | CNC - Ebitda

Stock Price
58.70
Daily Change
-0.11 -0.19%
Monthly
56.12%
Yearly
-2.26%
Q2 Forecast
54.80

Centene reported $2.56B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Acadia Healthcare USD 144.22M 44.37M Mar/2026
Addus HomeCare USD 44.51M 5.82M Mar/2026
Brookdale Senior Living USD 105.56M 5.51M Dec/2025
Cardinal Health USD 1.09B 109M Mar/2026
Centene USD 2.56B 3.47B Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 2.86B 56M Mar/2025
Community Health Systems USD 395M 19M Dec/2025
Cross Country Healthcare USD 4.07M 2.46M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
DaVita Healthcare Partners USD 659.83M 112.87M Mar/2026
Elevance Health USD 4.21B 2.02B Mar/2026
Encompass Health USD 348.8M 13.2M Mar/2026
Ensign USD 171.16M 11.4M Mar/2026
HCA USD 3.8B 312M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Humana USD 2.06B 2.35B Mar/2026
IQVIA Holdings USD 932M 114M Mar/2026
Laboratory Of America USD 605.6M 17.5M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Molina Healthcare USD 267M 385M Mar/2026
Option Care Health USD 104.77M 21.23M Mar/2026
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Select Medical USD 141.57M 41.43M Mar/2026
Tenet Healthcare USD 1.16B 21M Mar/2026
UnitedHealth USD 9.99B 8.5B Mar/2026
Universal Health Services USD 678.67M 8.07M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022